The Colorado-based company, founded in 2001, specializes in orthobiologics and focuses on its proprietary biomimetic small peptide molecule (P-15) for spinal applications. Their technology is designed to stimulate natural bone healing processes and provide a bone graft substitute for use in spinal fusion surgery and other orthopedic procedures, offering physicians a safer and more predictable alternative to commercially available bone growth factors.